1-2 of 2
Harriet Harder
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab in Combination with CHOP in Patients with Follicular Lymphoma: Analysis of Treatment Outcome of 552 Patients Treated in a Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG) after a Follow up of 58 Months

Christian Buske, Eva Hoster, Martin Dreyling, Roswitha Forstpointner, Michael Kneba, MD, PhD, Norbert Schmitz, Rudolf Schmits, Bernd Metzner, Marcel Reiser, Eva Lengfelder, Bernhard J Woermann, Harriet Harder, Susanna Hegewisch-Becker, Wolfgang E. Berdel, Georg Hess, Hartmut Eimermacher, Ali Aldaoud, Manfred Planker, Michael Unterhalt, Wolfgang Hiddemann, MD
Journal: Blood
Blood (2008) 112 (11): 2599.
https://doi.org/10.1182/blood.V112.11.2599.2599
Published: 2008
Journal Articles

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

Clinical Trials & Observations
Wolfgang Hiddemann, Michael Kneba, Martin Dreyling, Norbert Schmitz, Eva Lengfelder, Rudolf Schmits, Marcel Reiser, Bernd Metzner, Harriet Harder, Susanna Hegewisch-Becker, Thomas Fischer, Martin Kropff, Hans-Edgar Reis, Mathias Freund, Bernhard Wörmann, Roland Fuchs, Manfred Planker, Jörg Schimke, Hartmut Eimermacher, Lorenz Trümper, Ali Aldaoud, Reza Parwaresch, Michael Unterhalt
Journal: Blood
Blood (2005) 106 (12): 3725–3732.
https://doi.org/10.1182/blood-2005-01-0016
Published: 2005